About BrightGene
BrightGene is a company based in Suzhou (China) founded in 2001. BrightGene has raised $80 million across 2 funding rounds from investors including GF Securities, Highlight Capital Partners and Sequoia Capital. BrightGene offers products and services including Formulations and Active Pharmaceutical Ingredients.
- Headquarter Suzhou, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 博瑞生物医药（苏州）股份有限公司
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
$173.99 M (USD)8.55as on Dec 31, 2024
-
Net Profit
$25.92 M (USD)-6.57as on Dec 31, 2024
-
EBITDA
$42.95 M (USD)8.88as on Dec 31, 2024
-
Total Equity Funding
$80 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
GF Securities
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BrightGene
BrightGene offers a comprehensive portfolio of products and services, including Formulations and Active Pharmaceutical Ingredients.
Formulations are developed and supplied for medical purposes.
Active pharmaceutical ingredients and intermediates are produced for drug manufacturing.
Funding Insights of BrightGene
BrightGene has successfully raised a total of $80M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BrightGene
BrightGene has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include GF Securities, Highlight Capital Partners and Sequoia Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Provider of investment & asset management and financial services
|
Locked | Locked | Locked | |
|
Venture capital firm focused on early-stage investments
|
Locked | Locked | Locked |
Investor details for BrightGene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BrightGene
Investment portfolio details for BrightGene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BrightGene
Detailed financials for BrightGene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brightgene Comparisons
Peer comparison for BrightGene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BrightGene
Detailed competitors of BrightGene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brightgene
Complete news archive for BrightGene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BrightGene
BrightGene was founded in 2001 and raised its 1st funding round 18 years after it was founded.
BrightGene is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
BrightGene is a funded company, having raised a total of $80M across 2 funding rounds to date.
Annual revenue of BrightGene is $173.99M as on Dec 31, 2024.
Established in 2001 in Suzhou, China, BrightGene focuses on the pharmaceutical industry. Formulations for human use, active pharmaceutical ingredients, and veterinary drugs are developed and produced. A research and development system is utilized to drive innovation and ensure quality control. Production processes are supported by integrated systems for manufacturing and compliance, with operations centered on pharmaceutical and veterinary sectors.
BrightGene offers Formulations and Active Pharmaceutical Ingredients.
BrightGene has 3 investors. Key investors include GF Securities, Highlight Capital Partners, and Sequoia Capital.